(September 20, 2016, 1:44 PM EDT) -- NEW YORK — A shareholder filed a class action complaint in a New York federal court on Aug. 31, alleging that a dialysis services provider and certain of its executive officers issued a series of false and misleading statements concealing the company’s involvement in a fraudulent scheme to drive patients away from Medicare and Medicaid health care plans and into more expensive Patient Protection and Affordable Care Act (ACA) plans in order to obtain greater reimbursement for their services in violation of federal securities laws (Christine Gelsleichter v. American Renal Associates Holdings Inc., et al., No. 16-6841, S.D. N.Y.)....